01
- Entity Type
- Diseases
- Relation Groups
- 2
- Relation Preview
- 16
Basic Information
Grouped by core information, identifiers, and descriptions.
Quick relations do not expand inferred candidates by default. Load path-derived ingredients or herbs when needed.
Core Information
- Disease Name
- Muscular Dystrophy
- Standard Disease Name
- muscular dystrophy
- MeSH Tree
- No data
- ICD-10
- G71.0
Identifiers
- DO ID
- No data
- MeSH ID
- D009136
- OMIM ID
- MTHU037519
- UMLS ID
- C0026850
- HPO ID
- No data
Description and Extensions
- Description
- NCI2016_02D:A group of inherited progressive muscle disorders characterized by muscle weakness and eventual death of the muscle tissues. Examples include Duchenne muscular dystrophy, Becker's muscular dystrophy, Emery-Dreifuss muscular dystrophy, facioscapulohumeral muscular dystrophy, and limb-girdle muscular dystrophy.|MSH2017_2016_08_12:A heterogeneous group of inherited MYOPATHIES, characterized by wasting and weakness of the SKELETAL MUSCLE. They are categorized by the sites of MUSCLE WEAKNESS; AGE OF ONSET; and INHERITANCE PATTERNS.|MEDLINEPLUS_20151021:<p>Muscular dystrophy (MD) is a group of more than 30 inherited diseases. They all cause muscle weakness and muscle loss. Some forms of MD appear in infancy or childhood. Others may not appear until middle age or later. The different types can vary in whom they affect, which muscles they affect, and what the symptoms are. All forms of MD grow worse as the person's muscles get weaker. Most people with MD eventually lose the ability to walk.</p> <p>There is no cure for muscular dystrophy. Treatments can help with the symptoms and prevent complications. They include physical and speech therapy, orthopedic devices, surgery, and medications. Some people with MD have mild cases that worsen slowly. Others cases are disabling and severe.</p> <p >NIH: National Institute of Neurological Disorders and Stroke</p>|HPO2016_07_04:The term dystrophy means abnormal growth. However, muscular dystrophy is used to describe primary myopathies with a genetic basis and a progressive course characterized by progressive skeletal muscle weakness and wasting, defects in muscle proteins, and histological features of muscle fiber degeneration (necrosis) and regeneration. If possible, it is preferred to use other HPO terms to describe the precise phenotypic abnormalities. [HPO:probinson, Neuromics:vstraub]|CSP2006:general term for a group of inherited disorders which are characterized by progressive degeneration of skeletal muscles.|CHV2011_02:an inherited disease where skeletal muscles are progressively weakened and wasted.|CHV2011_02:an inherited disease where skeletal muscles are progressively weakened and wasted.|CHV2011_02:an inherited disease where skeletal muscles are progressively weakened and wasted.|CHV2011_02:an inherited disease where skeletal muscles are progressively weakened and wasted.
Related
Related Entities
Direct relations and traceable candidates grouped by relation type.